Riskpilot← Back to searchSign inGet full accessDr. Malkomian AB
ABActiveOrg 5569391583Franzéngatan 75Hospital activities · NACE 8610Est. 20130 employees
Revenue 2025
SEK 53K
-89% vs 2024
EBITDA margin
-222.7%
-212% vs 2024
Equity ratio
92.6%
Financial strength
Net profit 2025
SEK -379
-100% vs 2024
| Revenue | SEK 53K | -89% |
| EBITDA | SEK -119K | -212% |
| Net profit | SEK -379 | -100% |
| Total assets | SEK 1,1M | -15% |
| Equity | SEK 990K | -17% |
| Employees | 0 | — |
Legal name
Dr. Malkomian AB
Org number
5569391583
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
14 augusti 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom akutsjukvård och hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Franzéngatan 75
Email
arin_81@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 164 | 945 | 928 | 494 | 53 |
| Staff expenses | — | −270 | −295 | −266 | −10 |
| EBITDA | 1 011 | 543 | 481 | 106 | −119 |
| Depreciation & amort. | −0 | — | — | — | −17 |
| EBIT | 1 011 | 543 | 481 | 106 | −136 |
| Net financials | — | −0 | −0 | 0 | 136 |
| Profit before tax | 1 011 | 543 | 481 | 106 | 0 |
| Tax | −216 | −113 | −100 | −22 | −0 |
| Net profit | 795 | 430 | 381 | 84 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 294 | 1 373 | 1 415 | 1 257 | 1 069 |
| Equity | 1 045 | 1 175 | 1 306 | 1 190 | 990 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 249 | 197 | 109 | 66 | 79 |
| Total debt | 249 | 197 | 109 | 66 | 79 |
EBITDA margin
-222.7%
This company
15.8%
Market median
-1509% vs market
20212025
Equity ratio
92.6%
This company
38.2%
Market median
+142% vs market
20212025
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Malkomian AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arin Malkomian | Chief Executive Officer | 0 companies |
| Elena Gennadievna Malkomian | Deputy Board Member | 0 companies |